Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Merit Medical Systems (MMSI) EBIT (2016 - 2025)

Merit Medical Systems (MMSI) has disclosed EBIT for 16 consecutive years, with $54.2 million as the latest value for Q4 2025.

  • Quarterly EBIT rose 161.85% to $54.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $184.7 million through Dec 2025, up 486.43% year-over-year, with the annual reading at $184.7 million for FY2025, 486.43% up from the prior year.
  • EBIT hit $54.2 million in Q4 2025 for Merit Medical Systems, up from $42.6 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $54.2 million in Q4 2025 to a low of -$87.6 million in Q4 2024.
  • Historically, EBIT has averaged $15.9 million across 5 years, with a median of $24.8 million in 2022.
  • Biggest five-year swings in EBIT: soared 24792.19% in 2021 and later crashed 281.74% in 2022.
  • Year by year, EBIT stood at $21.9 million in 2021, then plummeted by 281.74% to -$39.8 million in 2022, then plummeted by 67.85% to -$66.8 million in 2023, then crashed by 31.2% to -$87.6 million in 2024, then skyrocketed by 161.85% to $54.2 million in 2025.
  • Business Quant data shows EBIT for MMSI at $54.2 million in Q4 2025, $42.6 million in Q3 2025, and $46.9 million in Q2 2025.